Brazil aims for maturity in device regulation
This article was originally published in SRA
Brazil's medical device regulatory agency, Anvisa, has launched several new legal instruments and initiatives that should make the $6 billion medtech market at once better regulated and more attractive for medtech manufacturers at home and abroad.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.